NCT00344682View on ClinicalTrials.gov

Memantine Augmentation of Antidepressants

PHASE4CompletedINTERVENTIONAL

Enrollment

31

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Depressive Disorder

Interventions

DRUG

memantine

memantine 5mg - 20mg PO daily

DRUG

Placebo

5mg - 20mg PO daily over 8 weeks

Trial Locations (1)

01605

Center for Psychopharmacologic Research and Treatment (University of Massachusetts Medical School), Worcester

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

University of Massachusetts, Worcester

OTHER